Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1982 Jun;66(6):386-8.
doi: 10.1136/bjo.66.6.386.

Oxytetracycline in the treatment of ocular rosacea: a double-blind trial

R S Bartholomew, B J Reid, M J Cheesbrough, M Macdonald, N R Galloway
Clinical Trial

Oxytetracycline in the treatment of ocular rosacea: a double-blind trial

R S Bartholomew et al. Br J Ophthalmol. 1982 Jun.

Abstract

Thirty-five patients with ocular rosacea were admitted to a trial of systemic oxytetracycline, 250 mg b.d. for 6 weeks. Oxytetracycline produced a significantly higher number of remissions than the placebo, 11/35. With repeated or continuous treatment 19/35 patients achieved a sustained remission for 8 months. There were no side effects. The nonspecific signs of ocular rosacea responded well to the treatment, but no permanent change in the conjunctival or corneal vascularisation occurred.

PubMed Disclaimer

References

    1. Br J Dermatol. 1966 Dec;78(12):649-52 - PubMed
    1. Trans Ophthalmol Soc U K. 1966;86:727-32 - PubMed
    1. Proc R Soc Med. 1969 Jan;62(1):11-2 - PubMed
    1. South Med J. 1970 Oct;63(10):1156-8 - PubMed
    1. Lancet. 1971 Nov 13;2(7733):1049-52 - PubMed

Publication types

Substances